nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—Drug interaction—Vincristine—muscle cancer	0.0254	0.0254	CcSEcCtD
Midodrine—Aphthous stomatitis—Doxorubicin—muscle cancer	0.0211	0.0211	CcSEcCtD
Midodrine—Urinary retention—Vincristine—muscle cancer	0.0163	0.0163	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.0146	0.0146	CcSEcCtD
Midodrine—Stomatitis—Dactinomycin—muscle cancer	0.0144	0.0144	CcSEcCtD
Midodrine—Dysuria—Vincristine—muscle cancer	0.0138	0.0138	CcSEcCtD
Midodrine—Scotoma—Doxorubicin—muscle cancer	0.013	0.013	CcSEcCtD
Midodrine—Stomatitis—Vincristine—muscle cancer	0.0128	0.0128	CcSEcCtD
Midodrine—Hyperaesthesia—Doxorubicin—muscle cancer	0.0126	0.0126	CcSEcCtD
Midodrine—Erythema multiforme—Dactinomycin—muscle cancer	0.0125	0.0125	CcSEcCtD
Midodrine—Flushing—Dactinomycin—muscle cancer	0.0123	0.0123	CcSEcCtD
Midodrine—Hepatic enzyme increased—Methotrexate—muscle cancer	0.0121	0.0121	CcSEcCtD
Midodrine—Chills—Dactinomycin—muscle cancer	0.0119	0.0119	CcSEcCtD
Midodrine—Urinary tract disorder—Vincristine—muscle cancer	0.0117	0.0117	CcSEcCtD
Midodrine—Urethral disorder—Vincristine—muscle cancer	0.0116	0.0116	CcSEcCtD
Midodrine—Vasodilation—Doxorubicin—muscle cancer	0.0113	0.0113	CcSEcCtD
Midodrine—Vasodilation procedure—Doxorubicin—muscle cancer	0.0113	0.0113	CcSEcCtD
Midodrine—Cardiac disorder—Vincristine—muscle cancer	0.011	0.011	CcSEcCtD
Midodrine—Angiopathy—Vincristine—muscle cancer	0.0107	0.0107	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.0106	0.0106	CcSEcCtD
Midodrine—Stomatitis—Etoposide—muscle cancer	0.0104	0.0104	CcSEcCtD
Midodrine—Mental disorder—Vincristine—muscle cancer	0.0104	0.0104	CcSEcCtD
Midodrine—Hepatobiliary disease—Etoposide—muscle cancer	0.0101	0.0101	CcSEcCtD
Midodrine—Back pain—Vincristine—muscle cancer	0.00996	0.00996	CcSEcCtD
Midodrine—Urinary tract disorder—Etoposide—muscle cancer	0.00946	0.00946	CcSEcCtD
Midodrine—Agitation—Vincristine—muscle cancer	0.00946	0.00946	CcSEcCtD
Midodrine—Urethral disorder—Etoposide—muscle cancer	0.00939	0.00939	CcSEcCtD
Midodrine—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00909	0.00909	CcSEcCtD
Midodrine—Erythema multiforme—Etoposide—muscle cancer	0.00906	0.00906	CcSEcCtD
Midodrine—Flushing—Etoposide—muscle cancer	0.00889	0.00889	CcSEcCtD
Midodrine—Cardiac disorder—Etoposide—muscle cancer	0.00889	0.00889	CcSEcCtD
Midodrine—Hypertension—Vincristine—muscle cancer	0.00889	0.00889	CcSEcCtD
Midodrine—Angiopathy—Etoposide—muscle cancer	0.00869	0.00869	CcSEcCtD
Midodrine—Chills—Etoposide—muscle cancer	0.0086	0.0086	CcSEcCtD
Midodrine—Nervous system disorder—Vincristine—muscle cancer	0.00824	0.00824	CcSEcCtD
Midodrine—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00822	0.00822	CcSEcCtD
Midodrine—Back pain—Etoposide—muscle cancer	0.00807	0.00807	CcSEcCtD
Midodrine—Pain—Dactinomycin—muscle cancer	0.00804	0.00804	CcSEcCtD
Midodrine—Muscle spasms—Etoposide—muscle cancer	0.00802	0.00802	CcSEcCtD
Midodrine—Irritability—Methotrexate—muscle cancer	0.00792	0.00792	CcSEcCtD
Midodrine—Feeling abnormal—Dactinomycin—muscle cancer	0.00775	0.00775	CcSEcCtD
Midodrine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00769	0.00769	CcSEcCtD
Midodrine—Insomnia—Vincristine—muscle cancer	0.0076	0.0076	CcSEcCtD
Midodrine—Paraesthesia—Vincristine—muscle cancer	0.00754	0.00754	CcSEcCtD
Midodrine—Abdominal pain—Dactinomycin—muscle cancer	0.00743	0.00743	CcSEcCtD
Midodrine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00725	0.00725	CcSEcCtD
Midodrine—Hypertension—Etoposide—muscle cancer	0.0072	0.0072	CcSEcCtD
Midodrine—Pain—Vincristine—muscle cancer	0.00718	0.00718	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00705	0.00705	CcSEcCtD
Midodrine—Abdominal discomfort—Methotrexate—muscle cancer	0.00687	0.00687	CcSEcCtD
Midodrine—Gastrointestinal pain—Vincristine—muscle cancer	0.00687	0.00687	CcSEcCtD
Midodrine—Confusional state—Etoposide—muscle cancer	0.00686	0.00686	CcSEcCtD
Midodrine—Asthenia—Dactinomycin—muscle cancer	0.00675	0.00675	CcSEcCtD
Midodrine—Dysuria—Methotrexate—muscle cancer	0.0067	0.0067	CcSEcCtD
Midodrine—Tachycardia—Etoposide—muscle cancer	0.00664	0.00664	CcSEcCtD
Midodrine—Abdominal pain—Vincristine—muscle cancer	0.00664	0.00664	CcSEcCtD
Midodrine—Skin disorder—Etoposide—muscle cancer	0.00661	0.00661	CcSEcCtD
Midodrine—Dry skin—Doxorubicin—muscle cancer	0.00658	0.00658	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00634	0.00634	CcSEcCtD
Midodrine—Stomatitis—Methotrexate—muscle cancer	0.00623	0.00623	CcSEcCtD
Midodrine—Paraesthesia—Etoposide—muscle cancer	0.00611	0.00611	CcSEcCtD
Midodrine—Dyspnoea—Etoposide—muscle cancer	0.00607	0.00607	CcSEcCtD
Midodrine—Somnolence—Etoposide—muscle cancer	0.00605	0.00605	CcSEcCtD
Midodrine—Hepatobiliary disease—Methotrexate—muscle cancer	0.00605	0.00605	CcSEcCtD
Midodrine—Asthenia—Vincristine—muscle cancer	0.00603	0.00603	CcSEcCtD
Midodrine—Rash—Dactinomycin—muscle cancer	0.00593	0.00593	CcSEcCtD
Midodrine—Gastrointestinal disorder—Etoposide—muscle cancer	0.00588	0.00588	CcSEcCtD
Midodrine—Pain—Etoposide—muscle cancer	0.00582	0.00582	CcSEcCtD
Midodrine—Dysuria—Doxorubicin—muscle cancer	0.0058	0.0058	CcSEcCtD
Midodrine—Pollakiuria—Doxorubicin—muscle cancer	0.00573	0.00573	CcSEcCtD
Midodrine—Urinary tract disorder—Methotrexate—muscle cancer	0.00567	0.00567	CcSEcCtD
Midodrine—Urethral disorder—Methotrexate—muscle cancer	0.00562	0.00562	CcSEcCtD
Midodrine—Feeling abnormal—Etoposide—muscle cancer	0.00561	0.00561	CcSEcCtD
Midodrine—Nausea—Dactinomycin—muscle cancer	0.00559	0.00559	CcSEcCtD
Midodrine—Gastrointestinal pain—Etoposide—muscle cancer	0.00557	0.00557	CcSEcCtD
Midodrine—Dizziness—Vincristine—muscle cancer	0.00556	0.00556	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00549	0.00549	CcSEcCtD
Midodrine—Erythema multiforme—Methotrexate—muscle cancer	0.00543	0.00543	CcSEcCtD
Midodrine—Stomatitis—Doxorubicin—muscle cancer	0.0054	0.0054	CcSEcCtD
Midodrine—Abdominal pain—Etoposide—muscle cancer	0.00538	0.00538	CcSEcCtD
Midodrine—Cardiac disorder—Methotrexate—muscle cancer	0.00533	0.00533	CcSEcCtD
Midodrine—Rash—Vincristine—muscle cancer	0.0053	0.0053	CcSEcCtD
Midodrine—Dermatitis—Vincristine—muscle cancer	0.00529	0.00529	CcSEcCtD
Midodrine—Headache—Vincristine—muscle cancer	0.00526	0.00526	CcSEcCtD
Midodrine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00523	0.00523	CcSEcCtD
Midodrine—Angiopathy—Methotrexate—muscle cancer	0.00521	0.00521	CcSEcCtD
Midodrine—Chills—Methotrexate—muscle cancer	0.00515	0.00515	CcSEcCtD
Midodrine—Bradycardia—Doxorubicin—muscle cancer	0.00506	0.00506	CcSEcCtD
Midodrine—Mental disorder—Methotrexate—muscle cancer	0.00503	0.00503	CcSEcCtD
Midodrine—Nausea—Vincristine—muscle cancer	0.00499	0.00499	CcSEcCtD
Midodrine—Urinary tract disorder—Doxorubicin—muscle cancer	0.00491	0.00491	CcSEcCtD
Midodrine—Asthenia—Etoposide—muscle cancer	0.00488	0.00488	CcSEcCtD
Midodrine—Urethral disorder—Doxorubicin—muscle cancer	0.00487	0.00487	CcSEcCtD
Midodrine—Back pain—Methotrexate—muscle cancer	0.00483	0.00483	CcSEcCtD
Midodrine—Pruritus—Etoposide—muscle cancer	0.00482	0.00482	CcSEcCtD
Midodrine—Erythema multiforme—Doxorubicin—muscle cancer	0.0047	0.0047	CcSEcCtD
Midodrine—Cardiac disorder—Doxorubicin—muscle cancer	0.00461	0.00461	CcSEcCtD
Midodrine—Flushing—Doxorubicin—muscle cancer	0.00461	0.00461	CcSEcCtD
Midodrine—Angiopathy—Doxorubicin—muscle cancer	0.00451	0.00451	CcSEcCtD
Midodrine—Dizziness—Etoposide—muscle cancer	0.0045	0.0045	CcSEcCtD
Midodrine—Chills—Doxorubicin—muscle cancer	0.00446	0.00446	CcSEcCtD
Midodrine—Mental disorder—Doxorubicin—muscle cancer	0.00435	0.00435	CcSEcCtD
Midodrine—Rash—Etoposide—muscle cancer	0.00429	0.00429	CcSEcCtD
Midodrine—Dermatitis—Etoposide—muscle cancer	0.00429	0.00429	CcSEcCtD
Midodrine—Headache—Etoposide—muscle cancer	0.00426	0.00426	CcSEcCtD
Midodrine—Flatulence—Doxorubicin—muscle cancer	0.00426	0.00426	CcSEcCtD
Midodrine—Tension—Doxorubicin—muscle cancer	0.00424	0.00424	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00422	0.00422	CcSEcCtD
Midodrine—Nervousness—Doxorubicin—muscle cancer	0.0042	0.0042	CcSEcCtD
Midodrine—Back pain—Doxorubicin—muscle cancer	0.00418	0.00418	CcSEcCtD
Midodrine—Muscle spasms—Doxorubicin—muscle cancer	0.00416	0.00416	CcSEcCtD
Midodrine—Confusional state—Methotrexate—muscle cancer	0.00411	0.00411	CcSEcCtD
Midodrine—Nausea—Etoposide—muscle cancer	0.00404	0.00404	CcSEcCtD
Midodrine—Nervous system disorder—Methotrexate—muscle cancer	0.004	0.004	CcSEcCtD
Midodrine—Agitation—Doxorubicin—muscle cancer	0.00397	0.00397	CcSEcCtD
Midodrine—Skin disorder—Methotrexate—muscle cancer	0.00396	0.00396	CcSEcCtD
Midodrine—Hypertension—Doxorubicin—muscle cancer	0.00373	0.00373	CcSEcCtD
Midodrine—Insomnia—Methotrexate—muscle cancer	0.00369	0.00369	CcSEcCtD
Midodrine—Anxiety—Doxorubicin—muscle cancer	0.00367	0.00367	CcSEcCtD
Midodrine—Paraesthesia—Methotrexate—muscle cancer	0.00366	0.00366	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00366	0.00366	CcSEcCtD
Midodrine—Dyspnoea—Methotrexate—muscle cancer	0.00363	0.00363	CcSEcCtD
Midodrine—Somnolence—Methotrexate—muscle cancer	0.00362	0.00362	CcSEcCtD
Midodrine—Dry mouth—Doxorubicin—muscle cancer	0.0036	0.0036	CcSEcCtD
Midodrine—Dyspepsia—Methotrexate—muscle cancer	0.00359	0.00359	CcSEcCtD
Midodrine—Confusional state—Doxorubicin—muscle cancer	0.00356	0.00356	CcSEcCtD
Midodrine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00352	0.00352	CcSEcCtD
Midodrine—Pain—Methotrexate—muscle cancer	0.00349	0.00349	CcSEcCtD
Midodrine—Nervous system disorder—Doxorubicin—muscle cancer	0.00346	0.00346	CcSEcCtD
Midodrine—Tachycardia—Doxorubicin—muscle cancer	0.00345	0.00345	CcSEcCtD
Midodrine—Skin disorder—Doxorubicin—muscle cancer	0.00343	0.00343	CcSEcCtD
Midodrine—Feeling abnormal—Methotrexate—muscle cancer	0.00336	0.00336	CcSEcCtD
Midodrine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00333	0.00333	CcSEcCtD
Midodrine—Abdominal pain—Methotrexate—muscle cancer	0.00322	0.00322	CcSEcCtD
Midodrine—Insomnia—Doxorubicin—muscle cancer	0.00319	0.00319	CcSEcCtD
Midodrine—Paraesthesia—Doxorubicin—muscle cancer	0.00317	0.00317	CcSEcCtD
Midodrine—Dyspnoea—Doxorubicin—muscle cancer	0.00315	0.00315	CcSEcCtD
Midodrine—Somnolence—Doxorubicin—muscle cancer	0.00314	0.00314	CcSEcCtD
Midodrine—Dyspepsia—Doxorubicin—muscle cancer	0.00311	0.00311	CcSEcCtD
Midodrine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00305	0.00305	CcSEcCtD
Midodrine—Pain—Doxorubicin—muscle cancer	0.00302	0.00302	CcSEcCtD
Midodrine—Asthenia—Methotrexate—muscle cancer	0.00292	0.00292	CcSEcCtD
Midodrine—Feeling abnormal—Doxorubicin—muscle cancer	0.00291	0.00291	CcSEcCtD
Midodrine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00289	0.00289	CcSEcCtD
Midodrine—Pruritus—Methotrexate—muscle cancer	0.00288	0.00288	CcSEcCtD
Midodrine—Abdominal pain—Doxorubicin—muscle cancer	0.00279	0.00279	CcSEcCtD
Midodrine—Dizziness—Methotrexate—muscle cancer	0.0027	0.0027	CcSEcCtD
Midodrine—Rash—Methotrexate—muscle cancer	0.00257	0.00257	CcSEcCtD
Midodrine—Dermatitis—Methotrexate—muscle cancer	0.00257	0.00257	CcSEcCtD
Midodrine—Headache—Methotrexate—muscle cancer	0.00255	0.00255	CcSEcCtD
Midodrine—Asthenia—Doxorubicin—muscle cancer	0.00253	0.00253	CcSEcCtD
Midodrine—Pruritus—Doxorubicin—muscle cancer	0.0025	0.0025	CcSEcCtD
Midodrine—Nausea—Methotrexate—muscle cancer	0.00242	0.00242	CcSEcCtD
Midodrine—Dizziness—Doxorubicin—muscle cancer	0.00233	0.00233	CcSEcCtD
Midodrine—Rash—Doxorubicin—muscle cancer	0.00223	0.00223	CcSEcCtD
Midodrine—Dermatitis—Doxorubicin—muscle cancer	0.00222	0.00222	CcSEcCtD
Midodrine—Headache—Doxorubicin—muscle cancer	0.00221	0.00221	CcSEcCtD
Midodrine—Nausea—Doxorubicin—muscle cancer	0.0021	0.0021	CcSEcCtD
